IP Library Assignment 062138/0206
Patent Assignment
Reel/Frame 062138/0206

Change of Name

Recorded: 2022-12-15 Pages: 5
Assignor
PRESBYOPIA THERAPIES, INC.
Executed: 2021-06-03
Assignee
LENZ THERAPEUTICS, INC.
18135 QUERIDA SOL, PO BOX 104, RANCHO SANTA FE, CALIFORNIA, 92067
Covered Properties (19)
Compositions and Methods for the Treatment of Presbyopia
Application: 61/882,998 →
Compositions and Methods for the Treatment of Presbyopia
Application: 61/904,510 →
Compositions and Methods for the Treatment of Presbyopia
Application: 61/917,620 →
Compositions and Methods for the Treatment of Presbyopia
Application: 61/938,438 →
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,089,562 →
Application: 14/223,639 →
Publication: US 2015/0065511
Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye
Patent: 9,320,709 →
Application: 14/742,903 →
Publication: US 2015/0290125
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,844,537 →
Application: 15/073,089 →
Publication: US 2016/0193193
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,833,441 →
Application: 15/073,139 →
Publication: US 2016/0193194
Compositions and Methods for the Treatment of Presbyopia
Application: 15/235,431 →
Publication: US 2016/0346259
Compositions and Methods for the Treatment of Presbyopia
Application: 15/864,703 →
Publication: US 2018/0140708
Contact Lens Compositions and Methods for the Treatment of Presbyopia
Application: 15/956,931 →
Publication: US 2018/0280363
Contact Lens Compositions and Methods for the Treatment of Presbyopia
Application: 16/385,107 →
Publication: US 2019/0240152
Compositions and Methods for the Treatment of Presbyopia
Application: 16/881,570 →
Publication: US 2020/0281906
Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye
Patent: 9,314,427 →
Application: 14/742,921 →
Publication: US 2015/0290126
Compositions and Methods for the Treatment of Presbyopia
Patent: 9,968,594 →
Application: 14/860,770 →
Publication: US 2016/0008337
Compositions and Methods for the Treatment of Presbyopia
Application: 14/860,777 →
Publication: US 2016/0008278
Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof
Application: 62/775,425 →
Compositions and Methods for the Treatment of Presbyopia
Application: 62/743,720 →
Compositions and Methods for the Treatment of Presbyopia
Application: 16/595,789 →
Publication: US 2020/0115377
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 23, 2013
From: GNT LLC.
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 031465/0328 →
Assignment of Assignor's Interest Oct 23, 2013
From: HORN, GERALD; NORDAN, LEE
To: GNT LLC.
Reel/Frame 031465/0298 →
Assignment of Assignor's Interest Mar 25, 2014
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 032516/0897 →
Assignment of Assignor's Interest Nov 10, 2015
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 037001/0001 →
Assignment of Assignor's Interest May 26, 2020
From: AYOUB, MIMOUN; CORDEN PHARMA SWITZERLAND LLC
To: CORDEN PHARMA SWITZERLAND LLC; NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 052747/0307 →
Assignment of Assignor's Interest May 28, 2020
From: MIMOUN, AYOUB
To: CORDEN PHARMA SWITZERLAND LLC
Reel/Frame 052776/0877 →
Assignment of Assignor's Interest Jun 5, 2020
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES, LLC
Reel/Frame 052849/0632 →
Assignment of Assignor's Interest Jun 11, 2020
From: HORN, GERALD
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 052909/0608 →
Change of Name Nov 9, 2020
From: PRESBYOPIA THERAPIES, LLC
To: PRESBYOPIA THERAPIES, INC.
Reel/Frame 054363/0516 →
Change of Name Dec 15, 2022
From: PRESBYOPIA THERAPIES, LLC
To: PRESBYOPIA THERAPIES, INC.
Reel/Frame 062138/0292 →
Change of Name Apr 2, 2024
From: LENZ THERAPEUTICS, INC.
To: LENZ THERAPEUTICS OPERATIONS, INC.
Reel/Frame 066978/0082 →